As India enters the third week of a nationwide lockdown, states are ramping up testing capacities. Asymptomatic patients, who were confined to their homes, are likely to start showing symptoms and massive testing is the only way to identify and isolate them. Further, with hotspots emerging across major cities, the country’s apex health research organisation — the Indian Council of Medical Research (ICMR) — has already advised resorting to rapid screening tests (using blood samples) at these containment zones to arrest the spread of the virus.
A quick review shows that most states are testing between 600 and 1,500 people